XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7636)	11/4/1998 7:14:00 PM
From: Robert S.	Read Replies (1) of 17367

I must say, it takes real chutzpah to make a statement like this Which brings me to the thought that time is short in hearing from the DSMB. Funny George how some are engrossed in sepsis* debate... after recently pronouncing the following To: StockDoc (6930 ) From: Bluegreen Wednesday, Aug 12 1998 6:41PM ET Reply # of 7642 Doc, Doc, Doc, Sepsis is like Cancer???? I liked how you slipped in gram positive example at this stage of the game. If you are serious about Xoma, how about doing some research on BPI especially rBPI21. You might want to check research also on BPI in regards to gram neg. sepsis. Let us concentrate on GRAM NEG. SEPTICEMIA* and also synergy with antibiotics first THEN let us deal with gram positive events shall we? What else at this stage? Well why don't you look at phase II results on Hemo. Trauma trial. Might you turn ARDS into a niche group also?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next